Paul Cate
Director Ejecutivo en Mark IV Capital, Inc. .
Perfil
Paul M.
Cate is currently the Chief Executive Officer at Mark IV Capital, Inc. since 1998 and the Chairman of the Board at PhageTech, Inc. since 2016.
He has an undergraduate degree from The California State University and a graduate degree from Golden Gate University.
Cargos activos de Paul Cate
| Empresas | Cargo | Inicio |
|---|---|---|
Mark IV Capital, Inc.
 Mark IV Capital, Inc. Investment ManagersFinance Mark IV Capital, Inc. is a real estate, private equity and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. | Director Ejecutivo | 01/12/1998 |
PhageTech, Inc.
 PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Presidente | 01/03/2016 |
Formación de Paul Cate.
| The California State University | Undergraduate Degree |
| Golden Gate University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Mark IV Capital, Inc.
Mark IV Capital, Inc. Investment ManagersFinance Mark IV Capital, Inc. is a real estate, private equity and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. and venture capital firm founded in 1974. The firm is headquartered in Newport Beach, California. | Finance |
PhageTech, Inc.
PhageTech, Inc. Miscellaneous Commercial ServicesCommercial Services PhageTech, Inc. provides medical services. The firm develops bacteriophage sensors related tests for detecting analytes in urine, blood, and other body fluids. Its technology is used for advanced diagnostics, such as early stage cancer detection, drug dosage monitoring, and time sensitive diseases and conditions. The company was founded by Richard W. Henson, Gregory Weiss, and Reginald Penner in 2014 and is headquartered in Irvine, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Paul Cate
